Beyond Air, Inc. (XAIR)
NASDAQ · Manufacturing · Surgical & medical instruments & apparatus
$2.93−$0.2400 (−7.57%) on the dayAs of the close; data may be delayed.
XAIR price, last 12 months
Key stats
- Previous close
- $3.17
- Open
- $3.14
- Day range
- $2.78 – $3.55
- 52-week range
- $2.78 – $55.60
- Volume
- 194.2K
- Avg volume (20 days)
- 547.1K
- Market cap
- $2.8M
Performance
1W−5.2%
1M−41.1%
3M−70.4%
6M−78.8%
YTD−79.8%
1Y−94.0%
vs S&P 500, 1Y−110.8 pts
Technicals and fundamentals
About Beyond Air, Inc.
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.
- Sector
- Manufacturing
- Industry
- Surgical & medical instruments & apparatus
- Listed on
- NASDAQ
- Market cap
- $2.8M